Three models of primary dysmenorrhea via estradiolbenzoate and oxytocin induction: an experimental study | [Rawal Medical Journal • 2024]

Author(s):

1. Sri Lestariningsih: Doctoral Program of Medical Sciences, Faculty of Medicine, Universitas Sebelas Maret, Surakarta, Central of Java, Indonesia; Midwifery Program, Tanjungkarang Ministry of Health Polytechnic, Metro City, Sumatera, Lampung, Indonesia

2. Didik Gunawan Tamtomo: Doctoral Program of Medical Sciences, Faculty of Medicine, Universitas Sebelas Maret, Surakarta, Central of Java, Indonesia

3. Sri Sulistyowati: Fetomaternal Division, Department of Obstetrics and Gynecology, Dr Moewardi Hospital, Faculty of Medicine, Universitas Sebelas Maret, Central of Java, Indonesia

4. Dono Indarto: Doctoral Program of Medical Sciences, Faculty of Medicine, Universitas Sebelas Maret, Surakarta, Central of Java, Indonesia; Department of Physiology, Faculty of Medicine, Universitas Sebelas Maret, Centralof Java, Indonesia; Biomedical Laboratory, Faculty of Medicine, Universitas Sebelas Maret, Central of Java, Indonesia

5. Imam Subadi: Department of Physical Medicine and Rehabilitation, Dr Soetomo General Hospital, Faculty of Medicine, Airlangga University, Surabaya, East Java, Indonesia

Abstract:

Objective: To evaluate the PGF2 profile and its association with symptoms in several models of primary dysmenorrhea. Methodogy: Forty Sprague Dawley rats were placed into four groups, each with ten rats: control, primary dysmenorrhea 1 (PD1), primary dysmenorrhea 2 (PD2), and primary dysmenorrhea 3 (PD3). The pain as main dysmenorrhea symptom was assessed by observing writhin glatency and frequency. The enzyme linked immunosorbent assay method was used to evaluate PGF2 levels in serum. Using hematoxyline eosin staining, the uterus was examined histopathologically. Results: The PD3 model had writhing characteristics, PGF2 levels, and degree of inflammation that are comparable to the PD2 model. Conclusion: Our proposed PD model has clinical and biomolecular and histopathological characteristics comparable to existing models. Thus, this new model can be an alternative for modeling primary dysmenorrhea.

Page(s): 1-5

DOI: DOI not available

Published: Journal: Rawal Medical Journal, Volume: 49, Issue: 1, Year: 2024

Keywords:

uterus , inflammation , Prostaglandins , Primaryd ysmenorrhea , experimental animal models

References:

[1] Burnett M,Lemyre M.,No M. .2017 .-primary dysmenorrhea consensus guideline. J Obstet. Gynaecol Can, 39(7) : 585-95.

[2] Durand H,Monahan K,McGuire BE .2021 .Prevalence and impact of dysmenorrhea among university students in Ireland. Pain Med, 22(12) : 2835-45.

[3] Iacovides S,Avidon I,Baker FC .2015 .What we know about primary dysmenorrhea today: a critical review. Hum Reprod Update, 21(6) : 762-78.

[4] Abreu-Sánchez A,Parra-Fernández ML,Onieva-Zafra MD,Ramos-Pichardo JD,Fernández-Martínez E .2020 .Type of dysmenorrhea, menstrual characteristics and symptoms in nursing students in Southern Spain. Healthcare, 8(3) : 302-6.

[5] Karout S,Soubra L,Rahme D,Karout L,Khojah HM,Itani R.,Prevalence R. .2021 .risk factors, and management practices of primary dysmenorrhea among young females. BMC Womens Health, 21(1) : 392.

[6] Ferries-Rowe E,Corey E,Archer JS .2020 .Primary dysmenorrhea: diagnosis andtherapy. Obstet Gynecol, 136(5) : 1047-58.

[7] Gan J,Zhu S,Ma X,Ding X,Deng Y,Wang Y,Pt B .2024 .The effect of Ding-kun-dan comparing with Marvelon on primary dysmenorrhea: A prospective, double-blind, multicenter, randomized controlled trial. J Ethnopharmacol, 116975 : .

[8] .2004 .Cyclooxygenase-2 specific inhibitors in the treatment of dysmenorrhea. J Pediatr Adolesc Gynecol, 17(2) : 75-79.

[9] Dawood MY,Khan-Dawood FS .2007 .Clinical efficacy and differential inhibition of menstrual fluid prostaglandin F2alpha in a randomized, double-blind, cross over treatment with placebo, acetaminophen, andibuprofen in primary dysmenorrhea. Am J Obstet Gynecol, 196(1) : e1-e35.

[10] Chen YX,Ma K. .2015 .Evaluation of clinical application of Dingkun Dan. Zhongguo Zhong Yai Za Zhi, 40(20) : 3916-9.

[11] Macedo CAF,de Paiva GO,Menezes PMN,Ribeiro TF,Brito MC,Vilela DAD .2022 .Lippiaoriganoides essential oil induces tocolytic effect in virginrat uterus and inhibits writhing in a dysmenorrhea mouse model. J Ethnopharmacol, 290(23) : 115099.

[12] Li X,Guo S,Chen Z,Ren K,Zhang H,Yu S .2021 .Regulation of mild moxibustion on uterine vascular and prostaglandin contents in primary dysmenorrhea rat model. Evid Based Complement Alternat Med, : 9949642.

[13] Bi W,Zhao J,Wang L,Wu C,Zhang W,L W .2021 .Preventive effect of different citrus essential oil son primary dysmenorrhea: in vivoandin vitrostudy. Food Biosci, 42 : 101135.

[14] An G,Chen X,Li C,Zhang L,Wei M,Chen J .2020 .Pathophysiological changes in female rats with estrouscycle disorder induced by long-term heat stress. Biomed Res Int, : 4701563.

[15] Wang D,Cheng X,Fang H,Ren Y,Li X,Ren W .2020 .Effect of cold stress on ovarian & uterine microcirculation in rats and the role of endothelin system. Reprod Biol Endocrinol, 18 : 29-34.

[16] Nestler EJ,Hyman SE .2010 .Animal models of neuropsychiatric disorders. Nat Neurosci, 13(10) : 1161-9.

[17] Poznyak AV,Silaeva YY,Orekhov AN,Deykin AV .2020 .Animal models of human atherosclerosis: current progress. Braz J Med Biol Res, 53(6) : e9557.

[18] Belzung C,Lemoine M. .2011 .Criteria of validity for animal models of psychiatric disorders: focus on anxiety disorders and depression. Biol Mood Anxiety Disord, 1(1) : 9-14.

[19] Peng Y,Qing X,Shu H,Tian S,Yang W,Chen S .2021 .Proper animal experimental designs for preclinical research of biomaterials for intervertebral disc regeneration. BiomaterTransl, 2(2) : 91-142.

[20] Li J,Liu X,Jian M,Xu Y,Wang C,Hu Y .2023 .Wenjing Zhitong recipe exhibits potential anti-primary dysmenorrhea properties by inhibiting COX2 and PKC signaling pathway in rats induced by estradiolbenzoate and oxytocin. J Trad Chinese Med Sci, 10(3) : 296-309.

[21] Evans J,Salamonsen LA .2012 .Inflammation, leukocytes and menstruation. Rev Endocr Metab Disord, 13(4) : 277-88.

[22] Fajrin I,Alam G,Usman AN .2020 .Prostaglandin level of primary dysmenorrhea pain sufferers. EnfermeriaClinica, 30(Suppl 2) : 5-9.

[23] Chen LX,Hu DJ,Xu WF,Li SP,Zhao J .2021 .Identification andd etermination of fructooligosaccharides in snowchrysanthemum (Coreopsistinctorianutt. World J Tradit Chin Med, 7(1) : 78-85.

[24] Zhang F,Liu XL,Wang W,Dong HL,Xia YF,Ruan LP .2018 .Expression of MMIF, HIF-1α and VEGF in serum and endometrial tissues of patients with endometriosis. Curr Med Sci, 38(3) : 499-504.

Citations

Downloads

Views